We had mentioned in Wednesday’s closing report that Nifty, Sensex continue to be on an uptrend. The major indices of the Indian stock markets were range-bound on Thursday and closed with small losses over Wednesday’s close. On the NSE, there were 664 advances, 1,064 declines and 338 unchanged. The trends of the major indices in the course of Thursday’s trading are given in the table below:
According to analysts, selling pressure was witnessed in the consumer durables, IT (information technology) and metal stocks. Riding high on Jio tide, Reliance Industries (RIL) Chairman and Managing Director Mukesh D Ambani on Thursday said the company has doubled its subscriber base to 215 million in 22 months. Announcing that the company's fixed line broadband service, JioGigaFiber, Ambani said: "We will now extend fiber connectivity to homes, merchants, small and medium enterprises and large enterprises simultaneously across 1,100 cities to offer the most advanced fiber-based broadband connectivity solutions." Starting this Independence Day, August 15 people can start registering for JioGigaFiber through both MyJio and Jio.com. Reliance Industries purchased 12.5% equity stake in Future101 Design Private Limited (Future101) for Rs9.50 crore.
Future101 was engaged in manufacturing, distribution and sale of luxury apparels in India. Reliance Industries shares closed at Rs964.45, down 2.57% on the NSE.
In corporate news today, Infosys has partnered with Siemens to develop Advanced IoT Engineering Solutions on MindSphere, the open cloud-based IoT OS from Siemens. MindSphere connects real things to the digital world and provides powerful industry applications & digital services to help drive business success. Infosys shares closed at Rs1,286.50, down 4.36% on the NSE.
Cadila Healthcare - CSIR-Imtech, a premier microbial institute under Ministry of Science and Technology, Government of India, has partnered with Zydus Cadila for development of newer drugs for drug-resistant infectious diseases. Cadila Healthcare shares closed at Rs388.00, down 1.70% on the NSE.
Suven Life Sciences has secured product patents in India, Singapore, South Korea and Israel corresponding to the new chemical entities for the treatment of disorders associated with neurodegenerative diseases and these patents are valid through 2031, 2034, 2034 and 2036 respectively. Suven Life Sciences shares closed at Rs218.10, down 0.07% on the NSE.
Dr Reddy’s Laboratories has launched Repatha™ (evolocumab) 140 mg/ml, the first and only PCSK9 Inhibitor* available in India, approved by the DCGI. Repatha™ (evolocumab) was a patented product of Amgen global. In India, Repatha™ was distributed by Dr Reddy's and manufactured by Amgen. Dr Reddy’s Laboratories shares closed at Rs2,297.95, down 0.55% on the NSE.
Bharti Infratel has received approval of Competition Commission of India (CCI) for the proposed merger of Bharti Infratel Limited and Indus Towers Limited. Bharti Infratel shares closed at Rs303.00, up 1.17% on the NSE.
IIFL Holdings - India Infoline Finance Limited, a subsidiary of the company, has raised Rs325 crore from CDC Group Plc, the United Kingdom's government-owned development finance institution through issue of INR Denominated Tier II Bonds. IIFL Holdings shares closed at Rs663.00, down 1.01% on the NSE.
Apollo Hospitals has acquired a 50% stake in Medics International Lifesciences Ltd., a 330 bedded super-speciality hospital in Lucknow for a consideration of Rs91 crores.
G M Breweries was the first to report the Q1FY18-19 results. It reported a 10.4% year-on-year (y-o-y) growth in total revenue at Rs404.45cr. The PAT jumped to Rs22.19 (117.5% y-o-y growth), resulting in a 6.98% y-o-y growth in EPS (Rs12.14).
The closing values of the top gainers and top losers are given in the table below:
The closing values of the major Asian indices are given in the table below: